IFF Elects David Epstein, Novartis, to Board of Directors
International Flavors & Fragrances Inc. (NYSE: IFF) (Euronext Paris: IFF), a leading innovator of sensory experiences that move the world, today announced David Epstein, Division Head, Novartis Pharmaceuticals has been elected to the Company's Board of Directors as of January 1, 2016. With this appointment, Mr. Epstein will also join the Company’s Audit Committee.
"David is a welcome addition to our Board. His extensive knowledge managing a global innovation-based company will complement the talent and leadership we currently have among our directors and help guide our progress as we execute our Vision 2020 business strategy," said Andreas Fibig, CEO and Chairman IFF.
Currently based in Switzerland, Mr. Epstein joined Novartis in 1989. Early roles included Vice-President, Sales and Marketing, Specialty Business Sector, Integration Officer, North America. More recent positions include Chief Operating Officer of Novartis Pharmaceuticals U.S. and President and Chief Executive Officer, Oncology and Molecular Diagnostics. Prior to Novartis and its predecessor companies, Mr. Epstein started his career at Booz Allen Hamilton. He has extensive experience in both the United States and abroad.
Mr. Epstein holds a bachelor’s degree in pharmacy from Rutgers University and a Master’s degree in finance and marketing from Columbia University.
International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for exploration drives us to co-create unique products that consumers taste, smell, or feel in fine fragrances and beauty, detergents and household goods, as well as beloved foods and beverages. Our 6,800 team members globally take advantage of leading consumer insights, research and development, creative expertise, and customer intimacy to develop differentiated offerings for consumer products. Learn more at www.iff.com , Twitter , Facebook , Instagram , and LinkedIn .
International Flavors & Fragrances Inc.
Michael DeVeau, 212-708-7164
VP, Global Corporate Communications & Investor Relations
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
PHARNEXT21.6.2018 20:25 | pressemeddelelse
Pharnext to Announce Top-Line Results from the Pivotal Phase 3 Trial of PXT3003 for the Treatment of Charcot-Marie-Tooth Type 1A Disease by October 2018
PHILIP-MORRIS-INTERNATIO21.6.2018 20:15 | pressemeddelelse
Philip Morris International Makes Call to Creative, Media and Communications Communities
IBC21.6.2018 18:32 | pressemeddelelse
IBC2018 Announces Cyber Security Forum to Help Media Tackle Cyber Threats
MENSIA-TECHNOLOGIES21.6.2018 18:25 | pressemeddelelse
Mensia Technologies Raises 1,3 Million Euro to Introduce Koala Neurofeedback as a Revolutionary Medical Device in Europe
PA-PHLEXGLOBAL21.6.2018 18:18 | pressemeddelelse
Phlexglobal to Improve eTMF Document Transfers with Adoption of New Exchange Mechanism Standard
IDEMIA21.6.2018 16:38 | pressemeddelelse
IDEMIA: Enter the World of Augmented Identity at our Pop-up Innovation Center in London (25th-27th June 2018)
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum